GlassScriptPhysician profile
Steven M Ariss
NPI 1720085566
$7,300.88
in general payments reported to CMS, 2019-2025
51 companies · $779 in 2025
The $779 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,768 · 2020: $352 · 2021: $1,036 · 2022: $1,290 · 2023: $1,050 · 2024: $1,027 · 2025: $779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,756 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,755.60 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $868.70 | 2019-2025 | Erleada |
| Astellas Pharma US INC | $579.77 | 2019-2025 | Xtandi, Myrbetriq |
| Pfizer INC. | $474.59 | 2019-2025 | |
| Rochester Medical Corporation | $383.04 | 2020-2022 | |
| C. R. Bard, INC. & Subsidiaries | $343.95 | 2023-2025 | Bard Urinary Drainage Bag, Personal Catheter Intermittent Catheter |
| Boston Scientific Corporation | $316.01 | 2019-2025 | General - Pain Management, Spaceoar Vue System - 10ml |
| Blue Earth Diagnostics | $285.67 | 2019-2025 | Posluma |
| Janssen Pharmaceuticals, INC | $266.86 | 2019-2022 | |
| Abbvie INC. | $262.67 | 2019-2024 | Vraylar, Botox |
| Myovant Sciences INC. | $249.80 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $239.05 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $233.26 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $218.25 | 2019-2024 | Provenge |
| Teleflex LLC | $207.69 | 2021-2025 | Urolift |
| Amgen INC. | $193.78 | 2023-2024 | Evenity, Prolia |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $155.36 | 2019 | |
| Allergan, INC. | $143.66 | 2019-2020 | |
| Tolmar Pharmaceuticals, INC. | $117.53 | 2019-2022 | |
| Inari Medical, INC. | $116.78 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Corcept Therapeutics | $115.00 | 2024 | Korlym |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.16 | 2019 | |
| Sumitomo Pharma America, INC. | $110.82 | 2023-2025 | Gemtesa, Orgovyx |
| Amarin Pharma, INC. | $110.00 | 2019 | |
| Tolmar, INC. | $103.85 | 2023-2025 | Eligard, Jatenzo |
| Olympus America INC. | $103.80 | 2022-2025 | Itind System |
| Merck Sharp & Dohme LLC | $101.02 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $98.33 | 2022-2025 | Pylarify |
| Antares Pharma, INC. | $92.08 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $77.98 | 2022 | |
| Coloplast Corp | $69.65 | 2023-2024 | Speedicath |
| Agiliti Surgical, INC. | $65.72 | 2023-2025 | Koelis Trinity Mri/US Fusion, Sonablate Hifu, Lumenis 100 Watt Versapulse Powersuite Holmium Laser |
| Urogen Pharma, INC. | $48.42 | 2023-2024 | Jelmyto |
| Endo USA, INC. | $46.62 | 2025 | Xiaflex |
| Convatec INC. | $36.98 | 2025 | |
| Novartis Pharmaceuticals Corporation | $32.26 | 2022-2025 | |
| Ferring Pharmaceuticals INC. | $31.69 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $31.04 | 2024-2025 | |
| Urovant Sciences INC | $29.47 | 2022 | |
| Smith+Nephew, INC. | $25.41 | 2019-2023 | Stravix |
| Accord Healthcare, INC. | $22.75 | 2025 | |
| Myriad Genetic Laboratories, INC. | $20.67 | 2025 | Prolaris |
| Laborie Medical Technologies Corp. | $20.66 | 2025 | |
| Ambu INC. | $18.67 | 2021 | |
| 180 Medical, INC. | $18.00 | 2024 | Cure Catheter |
| Tempus Ai, INC | $16.74 | 2024 | |
| Dentsply Ih INC. | $16.46 | 2019 | |
| Dentsply Ih Ab | $15.00 | 2025 | Lofric |
| Verity Pharmaceuticals INC. | $14.34 | 2023 | Trelstar |
| Procept Biorobotics Corporation | $13.32 | 2022 | |
| Cook Medical LLC | $12.50 | 2021 | |
| Acerus Pharmaceuticals Corporation | $12.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Ariss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.